LNP

(3alpha,9beta,10alpha,13alpha)-30-cyclopropylidenelanost-7-en-3-ol

Created:	2010-11-03
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where LNP is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	88
Chiral Atom Count	8
Bond Count	92
Aromatic Bond Count	0

2D diagram of LNP

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(3alpha,9beta,10alpha,13alpha)-30-cyclopropylidenelanost-7-en-3-ol
Systematic Name (OpenEye OEToolkits)	(3S,5S,9S,10R,13R,14S,17R)-14-(cyclopropylidenemethyl)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
Formula	C₃₃ H₅₄ O
Molecular Weight	466.781
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OC5C(C1C(C3C(=CC1)C4(\C=C2/CC2)C(CC3)(C)C(C(C)CCCC(C)C)CC4)(C)CC5)(C)C
SMILES	CACTVS	3.370	CC(C)CCC[CH](C)[CH]1CC[C]2(C=C3CC3)C4=CC[CH]5C(C)(C)[CH](O)CC[C]5(C)[CH]4CC[C]12C
SMILES	OpenEye OEToolkits	1.7.0	CC(C)CCCC(C)C1CCC2(C1(CCC3C2=CCC4C3(CCC(C4(C)C)O)C)C)C=C5CC5
Canonical SMILES	CACTVS	3.370	CC(C)CCC[C@@H](C)[C@H]1CC[C@@]2(C=C3CC3)C4=CC[C@@H]5C(C)(C)[C@@H](O)CC[C@]5(C)[C@@H]4CC[C@]12C
Canonical SMILES	OpenEye OEToolkits	1.7.0	C[C@H](CCCC(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@@H]3C2=CC[C@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C=C5CC5
InChI	InChI	1.03	InChI=1S/C33H54O/c1-22(2)9-8-10-23(3)25-16-20-33(21-24-11-12-24)27-13-14-28-30(4,5)29(34)17-18-31(28,6)26(27)15-19-32(25,33)7/h13,21-23,25-26,28-29,34H,8-12,14-20H2,1-7H3/t23-,25-,26-,28-,29+,31-,32-,33-/m1/s1
InChIKey	InChI	1.03	JMJLBCGVSMHFQK-SIDBGHOXSA-N

Related Resource References

Resource Name	Reference
PubChem	53497560

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.